, 10,31 ofTable two. Metabolites eceptors linical Trials.All-natural Metabolite-CAS# Receptor GPR43/GPR41 (FFA2 and FFA3) GPR43 (IUPHAR (#226)) GPR41 (IUPHAR # 227) gene#2865) GPR40 (FFA1) (IUPHAR-# 311) (gene#2864) GPR109A (HCA2) (IUPHAR-# 312) (gene #338442) 8-palmitate, PA (CAS#2210-62-0) 10-oleoylglycerol (CAS#111-03-5) GPR120 FFA4 (IUPHAR-# 127) (gene#338557) GPR119 (IUPHAR-# 126) (gene#139760) Trial Identify The Effect of PPI D1 Receptor Inhibitor MedChemExpress Treatment on Fat, Gut Microbiome, and Expression of GPR41 and GPR43 Impact of the Synbiotic within the Gut Microbiota and Adiposity-related Markers in Nutritious Obese Subjects Result of fermentable carbohydrates in glucose homeostasis Determination of Safety, Tolerability, Pharmacokinetics, Food Effect and pharmacodynamics of Single and Numerous Doses of P11187 Impact of Dietary oils as GPCR agonists on Glucose tolerance Short-term Result of Extended-release Niacin on Endothelial Function. Expression of G-protein Coupled Receptor 120 (GPR120) Receptor in Adipose Tissue of German Bcl-W Inhibitor site Diabetes Center (GDC) Cohort Subjects -Oleoyl Glycerol is really a GPR119 Agonist and Signals GLP-1 Release in People. Diet program oil supplementation induced release of GLP-1 Drug Food plan questionnaire Dietary Supplement Synbiotic Dietary supplement Inulin and cellulose GPR-40-agonist P11187 Dietary Supplement Pine nut and olive oil Niacin Na-OHB Association of R270H mutant with T2D and expression of GPR120 in T2D Dietary Supplement: GPR 119 agonist, 2-oleyl glycerol Dietary Supplement: Oleic acid Diet plan oil supplementation of olive and carrot oil bile acid (CDCA, chenodeoxycholic acid) oleanolic acid Dietary Supplement: oleic acid Acetaminophen Metformin Colesevelam CCK-8 GLP-1 secretion by means of TGR5 GLP-1 secretion by means of TGR5 in healthful and Cholecystectomized Topics Chenodeoxylic acid Colesevelam Clinical Trials Related to This Evaluate NCT02457104 NCT0215182 NCT01841073 NCT01874366 NCT04703361 NCT03774095 NCT01942291;2-Propionate-butyrate (CAS156-54-7)9-a-linoleic acid (CAS#60-33-3)NCTNCT01043445 NCTEffect of Bile Acids over the Secretion of Satiation Peptides in People 11-Lithocholic acid (434-13-9) GPBAR1 (TGR5) (IUPHAR #37) (gene#151306)NCTThe Affect of Gall Bladder Emptying and Bile Acids over the Human GLP-1-secretion Value of Meal Excess fat Articles and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Kind two Diabetes Individuals Bile Acid-induced GLP-secretion. A Review in Cholecystectomized Topics Result of Bile Acids on GLP-1 SecretionNCTNCT01374594 NCT01251510 NCTCells 2021, ten,32 ofTable 2. Cont. Pure Metabolite-CAS# Receptor GPR75 (IUPHAR #115) Gene#10936 SIPR1(EDG1) (gene#1901) (IUPHAR#275) BLT1 IUPHAR#271) IP (IUPHAR#345) (Gene#5739) Trial Title Drug Clinical Trials Relevant to This Evaluate Not recruiting yet20-HETE Sphingosine-1-phosphate, (CAS#26993-30-6) LTBGenetic and Dietary Predictors of Anti-platelet Response Efficacy, Security and Tolerability of BAF312 Compared to Placebo in Sufferers With Intracerebral Hemorrhage (ICH). Entire body Weight, Aspirin Dose and Pro-resolving Mediators Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Topics Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg.5mg Inhaled Nitric Oxide and Inhaled Prostacyclin Just after Cardiac Surgical procedure for Heart Transplant or LVAD Placement Epoprostenol in Pulmonary Embolism Thromboxane Receptor Antagonist to improve Endothelial Cell Perform Lipid and Glycogen Metabolism in Individuals With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations Aspirin Imp